AI Analysis
AI-generated analysis. Always verify with the original filing.
Microbot Medical Inc. issued a press release commending the American Medical Association’s policy to protect healthcare professionals from ionizing radiation, highlighting how its LIBERTY Endovascular Robotic System reduces radiation exposure by 92% in the ACCESS-PVI Study. The company commenced Limited Market Release of LIBERTY in late 2025 and plans Full Market Release at the SIR conference in April 2026.
Key Takeaways
1Commends AMA’s late 2025 policy on radiation protection for healthcare professionals
2LIBERTY System demonstrated 92% relative reduction in radiation exposure in ACCESS-PVI Study
3LIBERTY enables remote operation away from radiation source, reducing PPE reliance
4Limited Market Release of LIBERTY commenced in late 2025
5Full Market Release planned at SIR conference in April 2026
6LIBERTY is FDA cleared single-use robotic system for peripheral endovascular procedures